Patent Assignment
Reel/Frame 006369/0163
Sale / Transfer of Property
Recorded: 1992-11-16
Pages: 6
Assignor
RORER BIOTECHNOLOGY INC.
Executed: 1992-05-29
Assignee
RHONE-POULENC RORER PHARMACEUTICALS INC.
3C43 500 ARCOLA ROAD, P.O. BOX 1200, COLLEGEVILLE, PENNSYLVANIA, 19426
Covered Properties
(18)
Test for Assessing the Unsaturated Binding Capacity of Serumproteins Which Bind Thyroid Hormones
Patent:
4,252,782 →
Application:
05/947,056 →
Intercalation Inhibition Assay for Compounds That Interact with Dna or Rna
Patent:
4,257,774 →
Application:
06/057,739 →
Production of Human Ifn-Gamma (Immune) Interferon
Patent:
4,376,821 →
Application:
06/255,138 →
Production of Human Ifn-Gamma (Immune) Interferon
Patent:
4,376,822 →
Application:
06/255,139 →
Recombinant Dna Vector Encoding Human Endothelial Cell Growth Factor
Patent:
4,868,113 →
Application:
06/835,594 →
Sustained Production of Recombinant Gamma Interferon Using an Epstein-Barr Virus Replicon
Patent:
4,939,088 →
Application:
07/016,044 →
Recombinant Factor Viiic Derived Fragments
Patent:
4,980,456 →
Application:
07/034,828 →
Pharmaceutical Plasma Protein Formulations in Low Ionic Strength Media
Patent:
4,877,608 →
Application:
07/118,670 →
Heteroazabenzobicyclic Carboxamide 5-HT3 Antagonists
Patent:
4,933,445 →
Application:
07/277,610 →
Methods for Purification of Recombinantly Produced Proteins
Patent:
5,530,100 →
Application:
07/519,709 →
Fibroblast Growth Factor Receptors
Application:
07/549,587 →
Recombinant Factor Viiic Fragments
Patent:
5,149,637 →
Application:
07/585,766 →
Therapeutic Fragments of Von Willebrand Factor
Application:
07/717,942 →
Monoclonal Antibodies Specific to Human Epidermal Growth Factor Receptor and Therapeutic Methods Employing Same
Application:
07/760,852 →
Methods for the Inactivation of Viruses in Viral-Contaminated Pharmaceutical Compositions
Patent:
5,300,433 →
Application:
07/765,479 →
Pure Glia Maturation Factor
Patent:
5,270,452 →
Application:
07/785,185 →
Recombinant Human Endothelial Cell Growth Factor
Application:
07/799,859 →
Fibroblast Growth Factor Receptors
Application:
07/934,372 →
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Nov 5, 1980
From: SCHULMAN, GAIL E.; RICHARDSON CAROL L.
To: MELOY LABORATORIES, INC., A CORP. OF
Reel/Frame 003809/0349 →
Assignment of Assignors Interest.
Apr 17, 1981
From: BRAUDE IRWIN A.
To: MELOY LABORATORIES, INC., A CORP. OF D.C.
Reel/Frame 003880/0063 →
Assignment of Assignors Interest.
Apr 17, 1981
From: BRAUDE IRWIN A.
To: MELOY LABORATORIES, INC., A CORP. OF D.C.
Reel/Frame 003880/0062 →
Assignment of Assignors Interest.
Mar 3, 1986
From: JAYE, MICHAEL; BURGESS, WILSON; MACIAG, THOMAS; DROHAN, WILLIAM
To: MELOY LABORATORIES INC.
Reel/Frame 004525/0699 →
Assignment of Assignors Interest.
Nov 29, 1988
From: PELLETIER, JEFFREY C.; YOUSSEFYEH, RAYMOND D.; CAMPBELL, HENRY F.
To: RORER PHARMACEUTICAL CORPORATION, A CORP. OF DE
Reel/Frame 004978/0883 →
Security Interest
Jul 7, 1989
From: WHITTAKER BIOPRODUCTS, INC.
To: SECURITY PACIFIC NATIONAL BANK
Reel/Frame 005178/0129 →
Assignment of Assignors Interest.
Jun 20, 1990
From: AKNANA, LIDA Y.; MITSCHELEN, JONATHAN J.; HRINDA, MICHAEL E.; DARLING, THOMAS L.J.
To: RORER BIOTECHNOLOGY, INC.
Reel/Frame 005340/0668 →
Assignment of Assignors Interest.
Sep 14, 1990
From: DIONNE, CRAIG A.; JAYE, MICHAEL; SCHLESSINGER, JOSEPH
To: RORER BIOTECHNOLOGY, INC., A CORP. OF DE
Reel/Frame 005432/0792 →
Released by Secured Party
Oct 2, 1990
From: SECURITY PACIFIC NATIONAL BANK
To: WHITTAKER BIOPRODUCTS, INC.
Reel/Frame 005461/0643 →
Change of Name Effective on 09/10/1990
Nov 9, 1990
From: RORER PHARMACEUTICALS INC.
To: RHONE-POULENC RORER PHARMACEUTICALS INC.
Reel/Frame 005563/0007 →
Assignment of Assignors Interest.
Oct 7, 1991
From: HRINDA, MICHAEL E.; LEE, TED C.K.; PRIOR, CHRISTOPHER P.
To: RORER BIOTECHNOLOGY, INC.
Reel/Frame 005864/0120 →
Merger Effective on 09/13/1991DE
Oct 29, 1991
From: WHITTAKER BIOPRODUCTS, INC. A CORP. OF MARYLAND (MERGED INTO)
To: BIOWHITTAKER, INC. A CORP. OF DELAWARE
Reel/Frame 005939/0015 →
Assignment of Assignors Interest.
Nov 18, 1991
From: SCRIPPS CLINIC AND RESEARCH FOUNDATION
To: SCRIPPS RESEARCH INSTITUTE, THE, A CORP. OF CA
Reel/Frame 006167/0046 →
Assignment of Assignors Interest.
Dec 9, 1991
From: FARB, DAVID L.
To: RORER BIOTECHNOLOGY, INC., A CORPORATION OF DE
Reel/Frame 005938/0511 →
Assignment of Assignor's Interest
Sep 8, 1998
From: RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC.
To: CENTEON L.L.C.
Reel/Frame 009441/0845 →
Change of Name
Nov 2, 2000
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: AVENTIS PHARMACEUTICALS PRODUCTS INC.
Reel/Frame 011177/0854 →
Change of Name
Oct 2, 2001
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: AVENTIS PHARMACEUTICALS PRODUCTS INC.
Reel/Frame 012014/0604 →
Change of Name
Oct 4, 2001
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: AVENTIS PHARMACEUTICALS PRODUCTS INC.
Reel/Frame 012036/0167 →
Assignment of Assignor's Interest
Jan 8, 2002
From: AVENTIS PHARMACEUTICALS PRODUCTS INC.
To: GENCELL, INC.
Reel/Frame 012280/0901 →
Executive Order 9424, Confirmatory License
Nov 13, 2008
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021824/0289 →
Executive Order 9424, Confirmatory License
Nov 13, 2008
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021824/0291 →